0 false false false false false false false false false true false false false false false false No description of principal activity 2022-05-01 Sage Accounts Production Advanced 2021 - FRS102_2021 xbrli:pure xbrli:shares iso4217:GBP 11941039 2022-05-01 2023-04-30 11941039 2023-04-30 11941039 2022-04-30 11941039 bus:Director1 2022-05-01 2023-04-30 11941039 core:WithinOneYear 2023-04-30 11941039 core:WithinOneYear 2022-04-30 11941039 core:ShareCapital 2023-04-30 11941039 core:ShareCapital 2022-04-30 11941039 core:RetainedEarningsAccumulatedLosses 2022-04-30 11941039 bus:SmallEntities 2022-05-01 2023-04-30 11941039 bus:AuditExemptWithAccountantsReport 2022-05-01 2023-04-30 11941039 bus:FullAccounts 2022-05-01 2023-04-30 11941039 bus:SmallCompaniesRegimeForAccounts 2022-05-01 2023-04-30 11941039 bus:PrivateLimitedCompanyLtd 2022-05-01 2023-04-30
COMPANY REGISTRATION NUMBER: 11941039
P7 Healthcare Consulting Ltd
Filleted Unaudited Financial Statements
30 April 2023
P7 Healthcare Consulting Ltd
Balance Sheet
30 April 2023
2023
2022
Note
£
£
£
Current assets
Debtors
4
2,642
1,724
Cash at bank and in hand
4,769
4,851
-------
-------
7,411
6,575
Creditors: amounts falling due within one year
5
( 7,410)
( 5,725)
-------
-------
Net current assets
1
850
----
----
Total assets less current liabilities
1
850
----
----
Net assets
1
850
----
----
Capital and reserves
Called up share capital
1
1
Profit and loss account
849
----
----
Shareholders funds
1
850
----
----
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with Section 1A of FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
In accordance with section 444 of the Companies Act 2006, the profit and loss account has not been delivered.
For the year ending 30 April 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Director's responsibilities:
- The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476 ;
- The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements .
These financial statements were approved by the board of directors and authorised for issue on 13 October 2023 , and are signed on behalf of the board by:
Dr P Bain
Director
Company registration number: 11941039
P7 Healthcare Consulting Ltd
Notes to the Financial Statements
Year ended 30 April 2023
1. General information
The company is a private company limited by shares, registered in England and Wales. The address of the registered office is Churchgate House, Brafferton, York, YO61 2NZ.
2. Statement of compliance
These financial statements have been prepared in compliance with Section 1A of FRS 102, 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland'.
3. Accounting policies
Basis of preparation
The financial statements have been prepared on the historical cost basis, as modified by the revaluation of certain financial assets and liabilities and investment properties measured at fair value through profit or loss.
The financial statements are prepared in sterling, which is the functional currency of the entity.
Revenue recognition
Turnover is measured at the fair value of the consideration received or receivable for services rendered.
Corporation tax
The taxation expense represents the aggregate amount of current and deferred tax recognised in the reporting period. Tax is recognised in profit or loss, except to the extent that it relates to items recognised in other comprehensive income or directly in equity. In this case, tax is recognised in other comprehensive income or directly in equity, respectively. Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amounts of tax expected to pay or recover using the tax rates and laws that have been enacted or substantively enacted at the reporting date.
Deferred tax is recognised in respect of all timing differences at the reporting date. Unrelieved tax losses and other deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date that are expected to apply to the reversal of the timing difference.
Financial instruments
The company only enters into basic financial transactions that result in the recognition of financial assets and liabilities such as trade and other debtors and creditors, loans from banks and other third parties, and loans to related parties.
4. Debtors
2023
2022
£
£
Trade debtors
2,642
1,724
-------
-------
5. Creditors: amounts falling due within one year
2023
2022
£
£
Social security and other taxes
3,322
669
Other creditors
4,088
5,056
-------
-------
7,410
5,725
-------
-------